全文获取类型
收费全文 | 219篇 |
免费 | 13篇 |
国内免费 | 4篇 |
专业分类
儿科学 | 22篇 |
妇产科学 | 2篇 |
基础医学 | 18篇 |
口腔科学 | 2篇 |
临床医学 | 16篇 |
内科学 | 47篇 |
皮肤病学 | 2篇 |
神经病学 | 5篇 |
特种医学 | 83篇 |
外科学 | 14篇 |
综合类 | 5篇 |
预防医学 | 4篇 |
药学 | 9篇 |
肿瘤学 | 7篇 |
出版年
2022年 | 1篇 |
2021年 | 1篇 |
2020年 | 1篇 |
2019年 | 6篇 |
2018年 | 1篇 |
2017年 | 1篇 |
2016年 | 2篇 |
2015年 | 1篇 |
2014年 | 2篇 |
2013年 | 6篇 |
2012年 | 1篇 |
2011年 | 1篇 |
2010年 | 5篇 |
2009年 | 9篇 |
2008年 | 1篇 |
2007年 | 5篇 |
2006年 | 3篇 |
2004年 | 1篇 |
2003年 | 2篇 |
2002年 | 2篇 |
2001年 | 4篇 |
2000年 | 3篇 |
1999年 | 2篇 |
1998年 | 15篇 |
1997年 | 14篇 |
1996年 | 16篇 |
1995年 | 6篇 |
1994年 | 9篇 |
1993年 | 11篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 5篇 |
1989年 | 12篇 |
1988年 | 10篇 |
1987年 | 9篇 |
1986年 | 9篇 |
1985年 | 11篇 |
1984年 | 3篇 |
1983年 | 6篇 |
1982年 | 9篇 |
1981年 | 1篇 |
1980年 | 4篇 |
1979年 | 4篇 |
1978年 | 6篇 |
1977年 | 4篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1960年 | 1篇 |
1939年 | 1篇 |
1937年 | 1篇 |
排序方式: 共有236条查询结果,搜索用时 15 毫秒
141.
142.
Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice 总被引:16,自引:0,他引:16
Matsuda H; Watanabe N; Geba GP; Sperl J; Tsudzuki M; Hiroi J; Matsumoto M; Ushio H; Saito S; Askenase PW; Ra C 《International immunology》1997,9(3):461-466
Atopic dermatitis (AD) usually develops in patients with an individual or
family history of allergic diseases, and is characterized by chronic
relapsing inflammation seen especially in childhood, association with IgE
hyperproduction and precipitation by environmental factors. However, the
exact etiology of AD has been unclear. To further explore the pathogenesis
and treatment of AD, a suitable animal model is required. We found that
skin lesions, which were clinically and histologically very similar to
human AD, spontaneously appeared on the face, neck, ears and dorsal skin of
inbred NC/Nga mice when they were raised in non-sterile (conventional)
circumstances, but not under specific pathogen-free conditions. Plasma
levels of total IgE in conventional NC/Nga mice were markedly elevated from
8 weeks of age, correlating with clinical skin severity of dermatitis.
Immunohistochemical examination of the skin lesion showed increased numbers
of mast cells and CD4+ T cells containing IL-4 necessary for IgE synthesis.
Thus, NC/Nga mice suffered from dermatitis very similar to human AD with
IgE hyperproduction, which may be triggered by some environmental
factor(s).
相似文献
143.
144.
145.
Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML 总被引:2,自引:2,他引:2
Dunussi-Joannopoulos K; Weinstein HJ; Nickerson PW; Strom TB; Burakoff SJ; Croop JM; Arceci RJ 《Blood》1996,87(7):2938-2946
Recent studies have shown that tumor cells genetically modified by transduction of B7-1, a natural ligand for the T-cell costimulatory molecules CD28 and CTLA-4, are rejected in syngeneic hosts. In these reports, transformed cell lines and drug-selected cells have been used for vaccinations. To determine the effectiveness of B7-1-transduced primary acute myelogenous leukemia (AML) cells on the induction of antitumor immunity, we have studied a murine AML model in which primary AML cells were retrovirally transduced with the murine B7-1 cDNA. A defective retroviral producer clone expressing B7-1 and secreting a high titer of virus was used for infection of AML cells. Unselected transduced AML cells, expressing a high level of B7-1, were used for in vivo vaccinations. Our results show that one intravenous (IV) injection of irradiated B7-1-positive (B7-1+) AML cells can provide long-lasting (5 to 6 months) systemic immunity against subsequent challenge with wild-type AML cells. Furthermore, one exposure to irradiated B7-1+ AML cells results in rejection of leukemia by leukemic mice when the vaccination occurs in the early stages of the disease. The antileukemia immunity is CD8+ T-cell-dependent and B7/CD28-mediated, since in vivo treatment of mice with anti-CD8 monoclonal antibody or CTLA-4 Ig leads to abrogation of the specific antileukemia immune response. These results emphasize that B7-1 vaccines may have therapeutic usefulness for patients with AML. 相似文献
146.
Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients
The polymerase chain reaction (PCR) was used to detect hepatitis C (HCV) viral sequences (HCV-RNA) in clotting factor concentrates that had been stored at 4 degrees C for 1 to 16 years. A total of 43 concentrates were tested, comprising 31 batches of factor VIII, 6 of factor IX, 2 of antithrombin III, 3 of FEIBA, and 1 of factor VII. HCV- RNA was detected in 13 of the 43 batches (30.2%). Concentrates that had not undergone viral inactivation during manufacture were significantly more likely to contain detectable HCV-RNA than concentrates that had been virally inactivated (56.3% v 14.5%, P = .006). HCV sequences were more commonly detected in concentrates made from paid donor plasma than in those made from volunteer donor plasma (44% v 11%, P = .041), and more commonly in virally inactivated concentrates with pre-1989 than with post-1989 expiration dates (50% v 0%, P = .004). Of the four batches of heat-treated products that were HCV-RNA positive, at least three transmitted non-A, non-B hepatitis (NANBH). An association between the presence of HCV-RNA in concentrates and the development of NANBH was demonstrated in nine previously untreated patients on prospective follow-up. HCV-RNA was detected in the concentrates administered to the six patients whose alanine aminotransferase (ALT) abnormalities met the diagnostic criteria for NANBH and who later seroconverted for HCV, but it was not detected in the concentrates administered to the three patients whose ALT abnormalities failed to satisfy the diagnostic criteria and who did not seroconvert. We suggest that the use of this PCR technique to monitor clotting factor concentrates derived from pooled blood may potentially contribute to product safety. 相似文献
147.
JO Larkin TB Thekiso R Waldron K Barry PW Eustace 《Annals of the Royal College of Surgeons of England》2009,91(3):205-209
INTRODUCTION
Acute sigmoid volvulus is a well recognised cause of acute large bowel obstruction.PATIENTS AND METHODS
We reviewed our unit''s experience with non-operative and operative management of this condition. A total of 27 patients were treated for acute sigmoid volvulus between 1996 and 2006. In total, there were 62 separate hospital admissions.RESULTS
Eleven patients were managed with colonoscopic decompression alone. The overall mortality rate for non-operative management was 36.4% (4 of 11 patients). Fifteen patients had operative management (five semi-elective following decompression, 10 emergency). There was no mortality in the semi-elective cohort and one in the emergency surgery group. The overall mortality for surgery was 6% (1 of 15). Five of the seven patients managed with colonoscopic decompression alone who survived were subsequently re-admitted with sigmoid volvulus (a 71.4% recurrence rate). The six deaths in our overall series each occurred in patients with established gangrene of the bowel. With early surgical intervention before the onset of gangrene, however, good outcomes may be achieved, even in patients apparently unsuitable for elective surgery. Eight of the 15 operatively managed patients were considered to be ASA (American Society of Anesthesiologists) grade 4. There was no postoperative mortality in this group.CONCLUSIONS
Given the high rate of recurrence of sigmoid volvulus after initial successful non-operative management and the attendant risks of mortality from gangrenous bowel developing with a subsequent volvulus, it is our contention that all patients should be considered for definitive surgery after initial colonoscopic decompression, irrespective of the ASA score. 相似文献148.
A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice 总被引:6,自引:0,他引:6
The antithrombotic action of thrombomodulin was studied in mice. Rat and mouse thrombomodulin were isolated from lung acetone powders, and anti-rat thrombomodulin antibodies were prepared in rabbits. The antibodies neutralized both mouse (Kd approximately 150 nM) and rat thrombomodulin (Kd approximately 50 nM). A role for thrombomodulin in vivo was shown in mice injected intravenously (IV) with thrombin. All mice injected with 15 U thrombin (bolus) died of thromboembolism (mean survival 55 minutes), whereas those injected with a lower dosage survived. Prior injection with anti-rat thrombomodulin (1.8 mg IgG/mouse) potentiated the lethal effects of subsequent thrombin, whereas injection of thrombomodulin (isolated from mouse lung) prior to thrombin prolonged survival in a thrombomodulin concentration-dependent manner. The protective effect of thrombomodulin persisted for 30 minutes but after one hour thrombin injection was as toxic as in control animals. The half life (t1/2) for plasma clearance of 125I- mouse lung thrombomodulin was nine minutes. The major site of clearance was the liver, although thrombomodulin accumulated in several organs ten minutes after injection. The mechanism by which antithrombomodulin antibodies potentiated the lethal effects of thrombin was studied by measuring the protein C activating cofactor activity on vena cava removed from animals injected with antibodies. Protein C activation was inhibited by antibodies, suggesting a role for activated protein C in prevention of lethal thromboembolism. We found no effect of antibodies on the clearance of thrombin from mouse plasma, suggesting that blockade of endothelial endocytosis of thrombin does not play a significant role in the effects of antibodies. These results indicate that thrombomodulin participates in the defense against thrombosis in vivo. 相似文献
149.
Intrachromosomal recombinations involving F8A, in intron 22 of the factor VIII gene, and one of two homologous regions 500 kb 5' of the factor VIII gene result in large inversions of DNA at the tip of the X chromosome. The gene is disrupted, causing severe hemophilia A. Two inversions are possible, distal and proximal, depending on which homologous region is involved in the recombination event. A simple Southern blotting technique was used to identify patients and carriers of these inversions. In a group of 85 severe hemophilia A patients, 47% had an inversion, of which 80% were of the distal type. There was no association with restriction fragment length polymorphism (RFLP) haplotypes. The technique has identified a definitive genetic marker in families previously uninformative on RFLP analysis and provided valuable information for genetic counselling information may now be provided for carriers without the need to study intervening family members and the diagnosis of severe hemophilia A made in families with only a nonspecific history of bleeding. Analysis of intron 22 inversion should now be the first-line test for carrier diagnosis and genetic counselling for severe hemophilia A and may be particularly useful when there is no affected male family member or when intervening family members are unavailable for testing. 相似文献
150.